Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativity
A four-drug regimen for newly diagnosed high-risk multiple myeloma induced high…
Browsing Tag
regimen
Shorter TB Regimen Misses the Mark
Shorter high-dose rifampicin regimens proved safe for treating pulmonary…
FDA OKs New Frontline Endometrial Cancer Regimen, First in Decades
The FDA approved the immune checkpoint inhibitor dostarlimab (Jemperli) plus…
STRIDE Regimen Shows Manageable Safety in Unresectable Liver Cancer
The use of single tremelimumab (Imjudo) and regular interval durvalumab (Imfinzi; STRIDE…
Only 15,000 steps on a ‘lazy’ Sunday: Notes from a conductor’s exercise regimen
No two working days are the same for Sarah-Grace Williams, chief conductor of Sydney’s The Metropolitan Orchestra. Some days are spent on her feet in rehearsal and performance, moving to the…
Choosing a Treatment Regimen for Your Endometrial Cancer Patients
The conversation at the Society of Gynecologic Oncology (SGO) annual meeting was dominated by the two…
FDA Greenlights New First-Line Regimen in Bladder Cancer
The FDA gave accelerated approval to enfortumab vedotin (Padcev) and pembrolizumab…
CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
TAMPA, Fla. -- More than 70% of patients with unresectable, locally advanced vulvar carcinoma had complete responses to…
A new combination therapy regimen shows promising results for prostate cancer
TALAPRO-2, a study led by Neeraj Agarwal, MD, FASCO demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%.
Agarwal,…
FDA Panel Endorses New First-Line Lymphoma Regimen
Despite the concerns of FDA staff, agency advisors endorsed the inclusion of polatuzumab…